The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticals

James Kaufman, Nicholas Kalaitzandonakes
2011 Journal of Commercial Biotechnology  
Biologic pharmaceuticals have emerged to treat a number of diseases such as cancer and immune disorders. Although these drugs provide signifi cant benefi ts, they have tended to be costly to produce. Production technologies that grow biologic drugs in plants offer the potential to lower those costs. This article uses a system of simulation models to compare the economics of plant made pharmaceuticals (PMP) to incumbent productions systems. Although it is found that signifi cant cost savings are
more » ... nt cost savings are possible, R & D investment in PMPs continue to be limited, which suggests that there are a number of obstacles that limit adoption.
doi:10.1057/jcb.2010.37 fatcat:sjfmun6bu5b7biu5z3gqaoli2e